type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center amendment nbsp collaboration license agreement style margin margin bottom text indent font size font family time roman this amendment nbsp collaboration license agreement this amendment nbsp made effective january nbsp between proteostasis therapeutic corporation existing under state delaware having place business technology square style font size vertical align floor cambridge astellas pharma japanese corporation having principal place business nihonbashi honcho chome chuo tokyo japan astellas each astellas sometimes referred individually herein party collectively party style margin margin bottom text indent font size font family time roman reference hereby made that certain collaboration license agreement dated november nbsp amended nbsp nbsp august nbsp december nbsp between party agreement capitalized term used defined herein shall have meaning ascribed such term agreement style margin margin bottom text indent font size font family time roman whereas party wish further amend agreement pursuant term condition forth herein style margin margin bottom text indent font size font family time roman therefore consideration premise mutual covenant contained herein other valuable consideration receipt sufficiency which hereby acknowledged party hereby agree follows style margin margin bottom text indent font size font family time roman section nbsp deleted entirety replaced with following language style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign series following phase each project will present result phase will result phase accordance with guideline forth research plan series criterion guideline potential development path various screened active compound following presentation result phase astellas designate more series taken forward into optimization phase providing written notice later than july nbsp following conclusion phase active compound included series designated astellas taken forward into optimization phase will thereafter discontinued compound thereafter designated part series table style margin margin bottom text indent font size font family time roman party agree amend research plan conduct additional experiment additional experiment approved joint research committee under section nbsp astellas shall bear million dollar cost expense shall bear remaining cost expense necessary conduct additional experiment party agree that section nbsp nbsp agreement shall apply during period from february nbsp july nbsp style margin margin bottom text indent font size font family time roman except amended hereby other term agreement shall remain unchanged full force effect style margin margin bottom text indent font size font family time roman this amendment nbsp will governed construed accordance with state york without taking into consideration choice principle that would lead application another jurisdiction style page break before always size style color width align center style margin margin bottom font size font family time roman witness whereof party have caused this amendment nbsp executed their duly authorized representative style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width valign bottom width width style font family time roman font size valign colspan astellas pharma valign bottom nbsp valign valign bottom nbsp valign colspan proteostasis therapeutic style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom style border bottom solid nbsp valign style border bottom solid shunichiro matsumoto valign bottom nbsp valign valign bottom nbsp valign valign bottom style border bottom solid nbsp valign style border bottom solid meenu chhabra style font family time roman font size valign colspan style margin margin bottom font size font family time roman name shunichiro matsumoto style margin margin bottom font size font family time roman title vice president innovation management valign bottom nbsp valign valign bottom nbsp valign colspan style margin margin bottom font size font family time roman name meenu chhabra style margin margin bottom font size font family time roman title president chief executive officer table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center body html text document